Skip to main content
Caplight Logo









RealSeq Biosciences

RealSeq Biosciences

Private
Santa Cruz, CaliforniaHealthcare & Life Scienceshttps://www.realseq.com/

Last Round

Grant

Sep 17, 2025

Total Funding Raised

$9.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RealSeq Biosciences is a biotechnology company that develops RNA fragmentomics technology for real-time disease detection, biomarker discovery, and liquid biopsy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

RNA fragmentomicsNGSNGS library preparationnext-gen sequencingbiomarker discoveryRNA sequencingliquid biopsysmall RNA analysissingle-cell analysisbioinformaticsprecision medicineAI bioinformaticstranscriptome analysisbiotech R&Dmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RealSeq Biosciences Comparables

Compare RealSeq Biosciences with similar companies based on industry and business-model similarity.

RealSeq Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SomaGenics, Inc.
89%
Exai Bio
78%
Alithea Genomics
77%

RealSeq Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 17, 2025
GrantAug 15, 2025
SeedMar 1, 2024
GrantOct 9, 2023
SeedJul 28, 2023

Key People

Founding team and executive leadership

Sergio Barberan-Soler

Chief Executive Officer

Executive Team

Anne Scholz

COO

Executive Team

RealSeq Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2025

    $2M grant awarded by the National Institutes of Health.

  • Jul 28, 2023

    $5M raised led by TCA Venture Group and Tech Coast Angels.

RealSeq Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RealSeq Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RealSeq Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Cruz, California
Employee Range14
Year Founded2019
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?